NO921854D0 - Oral osmotisk doseringsform for fertilitetskontroll - Google Patents

Oral osmotisk doseringsform for fertilitetskontroll

Info

Publication number
NO921854D0
NO921854D0 NO921854A NO921854A NO921854D0 NO 921854 D0 NO921854 D0 NO 921854D0 NO 921854 A NO921854 A NO 921854A NO 921854 A NO921854 A NO 921854A NO 921854 D0 NO921854 D0 NO 921854D0
Authority
NO
Norway
Prior art keywords
dosage form
osmotic dosage
fertility control
oral osmotic
female
Prior art date
Application number
NO921854A
Other languages
English (en)
Other versions
NO921854L (no
Inventor
Jeri Dawn Wright
Jerry D Childers
Brian L Barclay
Patric S L Wong
Linda E Atkinson
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alza Corp filed Critical Alza Corp
Publication of NO921854D0 publication Critical patent/NO921854D0/no
Publication of NO921854L publication Critical patent/NO921854L/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0002Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Cosmetics (AREA)
  • Lubricants (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO92921854A 1989-11-16 1992-05-12 Oral osmotisk doseringsform for fertilitetskontroll NO921854L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/437,480 US5098714A (en) 1989-11-16 1989-11-16 Osmotic, oral dosage form for fertility control
PCT/US1990/006588 WO1991007173A1 (en) 1989-11-16 1990-11-12 Osmotic, oral dosage form for fertility control

Publications (2)

Publication Number Publication Date
NO921854D0 true NO921854D0 (no) 1992-05-12
NO921854L NO921854L (no) 1992-05-18

Family

ID=23736633

Family Applications (1)

Application Number Title Priority Date Filing Date
NO92921854A NO921854L (no) 1989-11-16 1992-05-12 Oral osmotisk doseringsform for fertilitetskontroll

Country Status (18)

Country Link
US (1) US5098714A (no)
EP (1) EP0500793B1 (no)
JP (1) JPH05501707A (no)
KR (1) KR920703024A (no)
AT (1) ATE96660T1 (no)
AU (1) AU640231B2 (no)
CA (1) CA2029647A1 (no)
DE (1) DE69004437T2 (no)
DK (1) DK0500793T3 (no)
ES (1) ES2060350T3 (no)
FI (1) FI922206A0 (no)
IE (1) IE62390B1 (no)
MX (1) MX174197B (no)
NO (1) NO921854L (no)
NZ (1) NZ236031A (no)
PT (1) PT95858B (no)
WO (1) WO1991007173A1 (no)
ZA (1) ZA909047B (no)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5200197A (en) * 1989-11-16 1993-04-06 Alza Corporation Contraceptive pill
FI93924C (fi) * 1991-09-17 1995-06-26 Martti Lauri Antero Marvola Menetelmä säädellysti lääkeainetta vapauttavan valmisteen valmistamiseksi
CA2150119C (en) * 1992-11-30 2005-03-15 Robert C. Cuca Tastemasked pharmaceutical materials
DE4344462C2 (de) 1993-12-22 1996-02-01 Schering Ag Zusammensetzung für die Empfängnisverhütung
US5914131A (en) * 1994-07-07 1999-06-22 Alza Corporation Hydromorphone therapy
US5552394A (en) * 1994-07-22 1996-09-03 The Medical College Of Hampton Roads Low dose oral contraceptives with less breakthrough bleeding and sustained efficacy
DE69530308T2 (de) * 1994-09-22 2003-10-16 Akzo Nobel Nv Verfahren zur herstellung von dosierungsformen durch feuchtgranulierung
US5595759A (en) * 1994-11-10 1997-01-21 Alza Corporation Process for providing therapeutic composition
US6096339A (en) * 1997-04-04 2000-08-01 Alza Corporation Dosage form, process of making and using same
US6919373B1 (en) 1996-11-12 2005-07-19 Alza Corporation Methods and devices for providing prolonged drug therapy
US5898032A (en) * 1997-06-23 1999-04-27 Medical College Of Hampton Roads Ultra low dose oral contraceptives with less menstrual bleeding and sustained efficacy
IL128818A0 (en) * 1998-03-12 2000-01-31 Akzo Nobel Nv Making dosage units using low shear granulation
DE19961897A1 (de) * 1999-12-20 2001-06-28 Basf Ag Verwendung eines Filmüberzuges als geschmacksmaskierendes Coating von pharmazeutischen Darreichungsformen
US6660726B2 (en) 2000-03-10 2003-12-09 Endeavor Pharmaceuticals Estrogenic compounds, pharmaceutical compositions thereof, and methods of using same
US7459445B2 (en) * 2000-03-10 2008-12-02 Duramed Pharmaceuticals, Inc. Estrogenic compounds and topical pharmaceutical formulations of the same
US6855703B1 (en) 2000-03-10 2005-02-15 Endeavor Pharmaceuticals Pharmaceutical compositions of conjugated estrogens and methods of analyzing mixtures containing estrogenic compounds
US7989436B2 (en) * 2003-07-23 2011-08-02 Duramed Pharmaceuticals, Inc. Estrogenic compounds and pharmaceutical formulations comprising the same
US20110104214A1 (en) 2004-04-15 2011-05-05 Purdue Pharma L.P. Once-a-day oxycodone formulations
EP1453521B1 (en) 2001-12-05 2013-09-04 Teva Women's Health, Inc. Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology
US6992075B2 (en) * 2003-04-04 2006-01-31 Barr Laboratories, Inc. C(14) estrogenic compounds
AU2004257772B2 (en) * 2003-07-16 2009-12-17 Teva Women's Health, Inc. Methods of hormonal treatment utilizing contraceptive regimens with continuous estrogen administration
US20070111975A1 (en) * 2004-10-07 2007-05-17 Duramed Pharmaceuticals, Inc. Methods of Hormonal Treatment Utilizing Ascending-Dose Extended Cycle Regimens
EP1853272A1 (en) * 2005-02-03 2007-11-14 Duramed Pharmaceuticals, Inc. Compositions of unconjugated estrogens and methods for their use
US20060183725A1 (en) * 2005-02-15 2006-08-17 Thomas Graeser Pharmaceutical preparation for oral contraception
WO2009132208A1 (en) * 2008-04-24 2009-10-29 Evestra, Inc. Oral contraceptive dosage forms comprising a progestogen dispersed in an enteric polymer and further comprising an estrogen
WO2010033832A2 (en) * 2008-09-19 2010-03-25 Evestra, Inc. Estriol formulations
WO2014113693A1 (en) * 2013-01-18 2014-07-24 University Of Utah Research Foundation Modified release osmotic pump for ph-responsive intravaginal drug delivery
EP3031747B1 (en) * 2014-12-11 2018-10-10 Henkel IP & Holding GmbH Dispensing pack comprising compressible foam/fibre inserts and method for varying the dispensing volume ratio of a dispensing pack

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2799241A (en) * 1949-01-21 1957-07-16 Wisconsin Alumni Res Found Means for applying coatings to tablets or the like
NL271831A (no) * 1960-11-29
US3845770A (en) * 1972-06-05 1974-11-05 Alza Corp Osmatic dispensing device for releasing beneficial agent
US4177256A (en) * 1973-04-25 1979-12-04 Alza Corporation Osmotic bursting drug delivery device
US3916899A (en) * 1973-04-25 1975-11-04 Alza Corp Osmotic dispensing device with maximum and minimum sizes for the passageway
GB1478759A (en) * 1974-11-18 1977-07-06 Alza Corp Process for forming outlet passageways in pills using a laser
US4077407A (en) * 1975-11-24 1978-03-07 Alza Corporation Osmotic devices having composite walls
US4063064A (en) * 1976-02-23 1977-12-13 Coherent Radiation Apparatus for tracking moving workpiece by a laser beam
US4111202A (en) * 1976-11-22 1978-09-05 Alza Corporation Osmotic system for the controlled and delivery of agent over time
GB2010676B (en) * 1977-12-27 1982-05-19 Alza Corp Diffusional drug delivery device with block copolymer as drug carrier
US4285987A (en) * 1978-10-23 1981-08-25 Alza Corporation Process for manufacturing device with dispersion zone
US4200098A (en) * 1978-10-23 1980-04-29 Alza Corporation Osmotic system with distribution zone for dispensing beneficial agent
US4372951A (en) * 1979-10-11 1983-02-08 Nichols Vorys Vaginal delivery for physiologic follicular-luteal steroid treatment
US4309996A (en) * 1980-04-28 1982-01-12 Alza Corporation System with microporous releasing diffusor
US4320759A (en) * 1980-04-28 1982-03-23 Alza Corporation Dispenser with diffuser
US4327725A (en) * 1980-11-25 1982-05-04 Alza Corporation Osmotic device with hydrogel driving member
US4449983A (en) * 1982-03-22 1984-05-22 Alza Corporation Simultaneous delivery of two drugs from unit delivery device
GB8319766D0 (en) * 1983-07-22 1983-08-24 Graham N B Controlled release device
US4772474A (en) * 1985-08-09 1988-09-20 Alza Corporation Dispenser with internal arrangement of lamina means for dispensing beneficial agent
US4764378A (en) * 1986-02-10 1988-08-16 Zetachron, Inc. Buccal drug dosage form
US4716496A (en) * 1986-05-09 1987-12-29 Eaton Corporation Panel-mounted control station housing
US4948593A (en) * 1989-05-15 1990-08-14 Alza Corporation Osmotic dosage form comprising an estrogen and a progestogen

Also Published As

Publication number Publication date
AU7786591A (en) 1991-06-13
PT95858A (pt) 1991-09-13
US5098714A (en) 1992-03-24
CA2029647A1 (en) 1991-05-17
ES2060350T3 (es) 1994-11-16
EP0500793A1 (en) 1992-09-02
ATE96660T1 (de) 1993-11-15
AU640231B2 (en) 1993-08-19
EP0500793B1 (en) 1993-11-03
FI922206A (fi) 1992-05-14
ZA909047B (en) 1991-09-25
IE904062A1 (en) 1991-05-22
IE62390B1 (en) 1995-01-25
NO921854L (no) 1992-05-18
NZ236031A (en) 1993-05-26
WO1991007173A1 (en) 1991-05-30
DE69004437T2 (de) 1994-03-03
FI922206A0 (fi) 1992-05-14
MX174197B (es) 1994-04-27
DE69004437D1 (de) 1993-12-09
PT95858B (pt) 1998-07-31
KR920703024A (ko) 1992-12-17
JPH05501707A (ja) 1993-04-02
DK0500793T3 (da) 1994-01-03

Similar Documents

Publication Publication Date Title
NO921854D0 (no) Oral osmotisk doseringsform for fertilitetskontroll
AU560487B2 (en) Contraceptive comprising gestodene and ethinylestradiol
BR8807426A (pt) Composicoes e metodos contraceptivos e controle do cancer de mama
ATE216241T1 (de) Sehr niedrigdosiertes orales kontrazeptiv mit weniger menstruationsblutungen und verzögerter wirkung
IL92069A0 (en) Contraception system and method
NO976067L (no) Farmasöytisk kombinasjonspreparat, sett og fremgangsmåte for hormonell prevensjon
IS4753A (is) Getnaðarvarnaraðferð og -samstæða fyrir kvenkyns spendýr, sem inniheldur samsetningu með gestageni og estrógeni
BG104451A (en) Antiestrogen and progestin-containing peroral contraceptives
LU90341I2 (fr) 75 Ug de désogestrel en l'absence éthinyl oestradiol (cerazette)
GR900100310A (en) Osmotic dosage form
Crist Post-coital estrogen